Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Diabetic Amputations Decreased From 1995 to 2005 in the UK
Link ID 2736
Title Diabetic Amputations Decreased From 1995 to 2005 in the UK
Url http://www.medscape.com/viewarticle/569352?src=rss
Description There was a significant reduction in diabetic amputations from 1995 to 2005 following improvements in foot care services, according to findings of a British study published in the January issue of Diabetes Care. Reuters Health Information
Category Articles > Diabetes and Endocrinology
Keywords
Date Jan 29, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Diabetes and Endocrinology
1. Sirolimus Stents May Reduce Restenosis in Diabetics With Coronary Disease
  Compared with paclitaxel-eluting stents (PES), sirolimus-eluting stents (SES) appear to decrease the risk of in-stent late luminal loss in diabetics with coronary artery disease, new research shows. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology


2. Sweet Drink Intake in Children May Not Increase Risk for Obesity
  A meta-analysis shows that children who consume sweet drinks do not have an increased risk for obesity; the association between sweet drink intake and body mass index was near zero. Medscape Medical News
Category:   Articles > Diabetes and Endocrinology


3. Glucose Challenge Better Than Random Glucose to Screen for Gestational Diabetes
  A prospective cohort study shows that the 50-g glucose challenge test is more effective than the random glucose test when screening for gestational diabetes. Medscape Medical News
Category:   Articles > Diabetes and Endocrinology


4. Insulin and Visually Impaired Patients
  How can diabetes educators help visually impaired diabetes patients manage insulin injections?
Medscape Diabetes & Endocrinology
Category:   Articles > Diabetes and Endocrinology


5. New DDP-4 Inhibitor Shows Safety, Efficacy in Type 2 Diabetes
  Almost half of patients with type 2 diabetes poorly controlled with diet and exercise or other antidiabetic agents were able to reach target hemoglobin A1C levels of less than 7.0% with a new, highly selective dipeptidyl peptidase-IV (DDP-4) inhibitor, alogliptin (SYR-32, Takeda Pharmaceutical Co.). Reuters Health Information
Category:   Articles > Diabetes and Endocrinology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS